| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J21-00 |
| filingDate |
1983-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cfc6dc52892ab603d76868826992a58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3da95067f90e6a52dd209b488e8223a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d65f5a23ca1c30b78f890ba27e25d15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4cd78529ecc7f61d8bdc940fcf2d8dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b689ed9744078cc777a98a3df1607b8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_863caa212961457b629b1f48ac1ddff1 |
| publicationDate |
1985-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-3330084-A1 |
| titleOfInvention |
7 (ALPHA) -ALKOXYCARBONYL-3-OXO-17 (ALPHA) -PREGN-4-EN-21,17-CARBOLACTONE AND THEIR 21-CARBONIC ACID SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PRODUCTS CONTAINING THEM |
| abstract |
7 alpha -Alkoxycarbonyl-3-oxo-17 alpha -pregn-4-ene-21,17-carbolactones and their 21-carboxylic acid salts of the general formula I <IMAGE> are described, in which R is an alkyl group with 1 to 4 carbon atoms <IMAGE> is a CC single or CC double bond or the group <IMAGE> and <IMAGE> is a CC single bond or the group <IMAGE> where at least one 1 alpha ,2 alpha - or 15 alpha ,16 alpha -methylene group must be present, and X is the group <IMAGE> where M is an alkali metal. The compounds of the general formula I have a strong antialdosterone action and low antiandrogenic side effects. |
| priorityDate |
1983-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |